News Scotland says yes to Truvada as PrEP The Scottish Medicines Consortium has approved the use of Gilead’s Truvada for use in preventing new HIV infections, so called pre-exposure prophylaxis (PrEP).
News NHS England confirms HIV prevention funding - but only via c... Large trial of HIV PrEP could lead to national programme
News Gilead donates Truvada to HIV trial patients PROUD trial patients can continue treatment for six months.
News EU approves Gilead's Truvada for HIV prevention But there are funding problems in UK, Australia and Canada.
News Outlook blindsided as FDA blocks wet AMD drug once again Shares in Outlook Therapeutics lost more than half their value after the FDA turned down the company's marketing application for its wet AMD therapy.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face